Loading
Latest filing published 09 Sept 2016 for Cynapsus Therapeutics Inc., €17.1M.
No signal scores available.
This profile gathers the share dealings of OrbiMed Advisors LLC in Cynapsus Therapeutics Inc. Between 6 July 2016 and 6 September 2016, the trades on record add up to 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 9 September 2016, the filings show a transaction worth €17.1M in Cynapsus Therapeutics Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations